The developing oligodendrocyte: key cellular target in brain injury in the premature infant
- 30 June 2011
- journal article
- review article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 29 (4), 423-440
- https://doi.org/10.1016/j.ijdevneu.2011.02.012
Abstract
Brain injury in the premature infant, a problem of enormous importance, is associated with a high risk of neurodevelopmental disability. The major type of injury involves cerebral white matter and the principal cellular target is the developing oligodendrocyte. The specific phase of the oligodendroglial lineage affected has been defined from study of both human brain and experimental models. This premyelinating cell (pre‐OL) is vulnerable because of a series of maturation‐dependent events. The pathogenesis of pre‐OL injury relates to operation of two upstream mechanisms, hypoxia‐ischemia and systemic infection/inflammation, both of which are common occurrences in premature infants. The focus of this review and of our research over the past 15–20 years has been the cellular and molecular bases for the maturation‐dependent vulnerability of the pre‐OL to the action of the two upstream mechanisms. Three downstream mechanisms have been identified, i.e., microglial activation, excitotoxicity and free radical attack. The work in both experimental models and human brain has identified a remarkable confluence of maturation‐dependent factors that render the pre‐OL so exquisitely vulnerable to these downstream mechanisms. Most importantly, elucidation of these factors has led to delineation of a series of potential therapeutic interventions, which in experimental models show marked protective properties. The critical next step, i.e., clinical trials in the living infant, is now on the horizon.Keywords
This publication has 160 references indexed in Scilit:
- A Clear and Present Danger: Endogenous Ligands of Toll-like ReceptorsNeuroMolecular Medicine, 2009
- Nitrosative stress and inducible nitric oxide synthase expression in periventricular leukomalaciaActa Neuropathologica, 2009
- Vitamin K prevents oxidative cell death by inhibiting activation of 12‐lipoxygenase in developing oligodendrocytesJournal of Neuroscience Research, 2009
- 17β‐estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brainJournal of Neuroscience Research, 2009
- Neonatal encephalitis and white matter injury: More than just inflammation?Annals of Neurology, 2008
- Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injuryAnnals of Neurology, 2008
- Glutamate transporter EAAT2 expression is up‐regulated in reactive astrocytes in human periventricular leukomalaciaJournal of Comparative Neurology, 2008
- Novel lipoxygenase inhibitors as neuroprotective reagentsJournal of Neuroscience Research, 2007
- Gray matter injury associated with periventricular leukomalacia in the premature infantActa Neuropathologica, 2007
- Developmental regulation of α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortexJournal of Comparative Neurology, 2006